文献速递消化内镜

麻醉支持与内镜医师主导镇静模式的效果比较:一项回顾性队列研究

Outcomes of anesthesia-supported versus endoscopist-driven sedation modalities: a retrospective cohort study.
PubMed 文献 · Gastrointest Endosc · 2025-01-27

该回顾性队列研究纳入2018年10月1日至2022年12月31日在佛罗里达州杰克逊维尔Mayo Clinic接受门诊食管胃十二指肠镜和/或结肠镜检查的成人(≥18岁)共56,361例,比较芬太尼/咪达唑仑、丙泊酚、丙泊酚±辅助药物及全身麻醉的恢复时间和不良事件。芬太尼/咪达唑仑组PACU停留时间显著长于其他各组,但不良事件发生率较低。

要点

  • 芬太尼/咪达唑仑组PACU停留时间显著长于丙泊酚、丙泊酚±辅助药物及全身麻醉组(P < .0001)。
  • 芬太尼/咪达唑仑组心动过缓8.39%、低氧血症6.12%、术后恶心呕吐0.24%、住院0.05%,低于其他镇静组。
  • 36项比较中30项的优势比显著低于1.00(P < .05)。

核心结论

  • 与丙泊酚、丙泊酚±辅助药物或全身麻醉相比,芬太尼/咪达唑仑镇静与较低的不良事件发生率相关,但PACU停留时间显著延长。

研究设计与样本

  • 回顾性队列研究,纳入2018年10月1日至2022年12月31日在佛罗里达州杰克逊维尔Mayo Clinic接受门诊食管胃十二指肠镜和/或结肠镜检查的成人(≥18岁),共56,361例。

主要发现

  • 芬太尼/咪达唑仑组平均PACU停留时间在食管胃十二指肠镜、结肠镜和联合操作中分别为52.01、49.68和53.24分钟,显著高于全身麻醉组(分别为44.65、41.41和41.92分钟)、丙泊酚±辅助药物组(分别为32.35、35.75和33.42分钟)及丙泊酚组(分别为31.63、32.61和33.29分钟)(P < .0001)。
  • 芬太尼/咪达唑仑组心动过缓发生率8.39%、低氧血症发生率6.12%、术后恶心呕吐发生率0.24%、住院率0.05%,这些发生率大幅低于其他镇静组。
  • 在操作、镇静药物和结局类别的36项比较中,有30项的优势比显著低于1.00(P < .05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The use of anesthesia has become commonplace in many procedural settings. The goal of this study is to compare sedation modalities used by endoscopists and anesthesiologists in the endoscopy suite, particularly with respect to recovery time and adverse events. METHODS: We conducted a retrospective cohort study including adults (≥18 years of age) undergoing outpatient EGD and/or colonoscopy at Mayo Clinic in Jacksonville, Florida between October 1st, 2018 and December 31st, 2022. Cases were classified as using propofol only, propofol ± adjuvants (PA; including dexmedetomidine, ketamine, fentanyl, and midazolam), general anesthesia (GA) with endotracheal tube, or fentanyl/midazolam (FM) only. The primary outcome was length of stay (LOS) in the postanesthesia care unit (PACU), and secondary outcomes included the incidence of postoperative nausea and vomiting (PONV), hypoxemia (Spo2 risk 90%), bradycardia (heart rate <60 bpm), and escalation of care (hospital admission). RESULTS: The analysis included 56,361 cases. Among patients who received FM sedation, the mean PACU LOS was 52.01, 49.68, and 53.24 minutes for EGD, colonoscopy, and combined procedures, respectively. This was significantly higher than the mean PACU LOS for GA (44.65, 41.41, and 41.92 minutes, respectively), for PA (32.35, 35.75, and 33.42 minutes, respectively), and for propofol (31.63, 32.61, and 33.29 minutes, respectively; P < .0001). Of patients receiving FM, 8.39% experienced bradycardia, 6.12% experienced hypoxia, 0.24% experienced PONV, and 0.05% were hospitalized. These were substantially lower than the rates for other sedation groups, and odds ratios were significantly lower than 1.00 (P < .05) in 30 of 36 comparisons across procedural, sedative, and outcome categories. CONCLUSIONS: Sedation achieved with FM correlated with a lower rate of adverse events but a significantly longer PACU LOS compared with propofol, PA, or GA.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Xie G, Estevez M, Heybati K, et al. Outcomes of anesthesia-supported versus endoscopist-driven sedation modalities: a retrospective cohort study. Gastrointest Endosc. 2025. PMID: 39880215. doi:10.1016/j.gie.2025.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。